HT
TVGN icon

Headlands Technologies’s Tevogen Inc. Common Stock TVGN Stock Holding History

Headlands Technologies’s Portfolio TVGN Stock Details TVGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-7
Closed -$368 – 1593
2025
Q1 		$368 Buy
+7
New +$460 ﹤0.01% 1076

Other funds holding TVGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
SEI Investments
SEI Investments Oaks, Pennsylvania $108B AUM 26.14% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Headlands Technologies's TVGN Position: Q2 2025 in Review

Headlands Technologies sold out of Tevogen Inc. Common Stock (TVGN) in Q2 2025, closing a stake of 7 shares — an estimated $368 sold.

Headlands Technologies first reported a position in TVGN in Q1 2025 and held it in 1 quarter. The position peaked at $368 in Q1 2025. 56 funds tracked by Wall St. Rank hold TVGN as of Q2 2025.

  • Headlands Technologies reported no remaining Tevogen Inc. Common Stock position as of Q2 2025 after selling out during the quarter.
  • Headlands Technologies sold 7 Tevogen Inc. Common Stock shares in Q2 2025, an estimated $368.
  • Headlands Technologies first reported a position in Tevogen Inc. Common Stock in Q1 2025 and held it in 1 quarter.
  • Headlands Technologies's Tevogen Inc. Common Stock position peaked at $368 in Q1 2025.
  • 56 funds tracked by Wall St. Rank held Tevogen Inc. Common Stock as of Q2 2025.

Based on Headlands Technologies's 13F filing for Q2 2025, filed 14 Aug 2025.